Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group
- 1 April 2000
- journal article
- clinical trial
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 25 (8) , 853-859
- https://doi.org/10.1038/sj.bmt.1702233
Abstract
Bone Marrow Transplantation is a high quality, peer-reviewed journal covering all aspects of clinical and basic haemopoietic stem cell transplantation.Keywords
This publication has 26 references indexed in Scilit:
- Liposomal amphotericin (AmBisome) is safe in bone marrow transplantation for primary immunodeficiencyBone Marrow Transplantation, 1997
- Antimycotic Therapy with Liposomal Amphotericin-B for Patients Undergoing Bone Marrow or Peripheral Blood Stem Cell TransplantationLeukemia & Lymphoma, 1997
- Amphotericin B prophylaxis against invasive fungal infections in neutropenic patients: A single center experience from 1980 to 1995Infection, 1996
- Fluconazole in the prophylaxis of fungal infection after bone marrow transplantationMycoses, 1996
- Fungal pneumonia: the predominant lung infection causing death in children undergoing bone marrow transplantationActa Paediatrica, 1996
- Fatal Outcome of Disseminated Candidosis after Allogeneic Bone Marrow Transplantation under Treatment with Liposomal and Conventional Amphotericin-B. A Report of 4 Cases with Determination of the Mic ValuesScandinavian Journal of Infectious Diseases, 1996
- Febrile neutropeniaCurrent Opinion in Oncology, 1993
- Prophylaxis and treatment of fungal infections with fluconazole in bone marrow transplant patientsMycoses, 1992
- A Controlled Trial of Fluconazole to Prevent Fungal Infections in Patients Undergoing Bone Marrow TransplantationNew England Journal of Medicine, 1992
- Low-dose amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantationThe American Journal of Medicine, 1991